Guidance for Chief Pharmacists and supporting documents to achieve Institutional Readiness and deployment of COVID-19 Treatments

Read first

Implementation of effective process control is essential to ensure that neutralising monoclonal antibody products are implemented safely.

nMABs

Casirivimab and imdevimab (Ronapreve)

Guidance for Chief Pharmacists and supporting documents to achieve Institutional Readiness and deployment of Ronapreve